IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Idexx Laboratories (IDXX) and Alcon (ALC). Idexx Laboratories (ID...

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Alcon (ALC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Idexx Laboratories (IDXX) with b...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Idexx Laboratories today and set a price target of $790.00. According...

Market Cap	$50.50B	P/E Ratio	38.07
52W High	$769.98	52W Low	$496.61
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	17.5%	52W Position	22.8%
Overall Score	44	Value Score	35
Quality Score	71	Technical Score	27

EPS Current Est	$14.68	EPS Next Est	$16.48
EPS Growth Est	+12.3%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IDXX	$558.93	-0.08%	150.28K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IDXX	$558.93	-0.1%	150.28K
3
4
5
6

IDXX

IDXX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get IDEXX Laboratories Inc. Data in Excel

Get IDEXX Laboratories Inc. Data in Excel